Related Experiment Video
Updated: Apr 12, 2026
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
8.1K
Advances in Statistical Approaches Oncology Drug Development
Anastasia Ivanova1, Gary L Rosner2, Olga Marchenko3
1Department of Biostatistics, University of North Carolina at Chapel Hill, NC, USA.
Therapeutic Innovation & Regulatory Science
|May 8, 2015
Summary
Recent statistical methods in oncology drug development are improving decision-making. Novel adaptive designs help accelerate Go/No-Go decisions while managing costs effectively.
Area of Science:
- Oncology
- Biostatistics
- Pharmaceutical Development
Background:
- Oncology drug development relies heavily on statistical methodologies.
- Academic and industry perspectives offer insights into current practices.
Purpose of the Study:
- To review recent advancements in statistical methodology and practice for oncology drug development.
- To highlight the role of these methods in improving decision-making processes.
Main Methods:
- Review of recent developments in statistical methodology.
- Focus on adaptive designs and their application in oncology.
- Analysis from both academic and industry viewpoints.
Main Results:
- Oncology is a leading area for the development of novel statistical methods.
- Adaptive designs have been significantly advanced and utilized in oncology.
- These methods facilitate more efficient Go/No-Go decision-making.
Conclusions:
- Statistical methodology continues to evolve, particularly within oncology.
- Novel approaches enhance the speed and quality of drug development decisions.
- Cost control remains a key consideration in implementing new statistical practices.
More Related Videos
Related Concept Videos
01:21Cancer Survival Analysis
844
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
844
01:24Kaplan-Meier Approach
755
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
755
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
565
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
565
01:20Actuarial Approach
379
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
379
01:20Comparing the Survival Analysis of Two or More Groups
719
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
719
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K